Supreme Court Reverses CCI Approval Revocation in the Amazon Future Group Dispute
The Supreme Court resolved a high-stakes legal battle over regulatory boundaries in India. The case involved the appellant, Amazon.com NV Investment Holdings LLC, and the Competition Commission of India. This landmark judgment clarifies the limits of statutory power held by antitrust regulators and reinforces the necessity of finality in corporate transactions. The conflict originated from […]
Supreme Court Rules on Civil Court Powers Regarding Interim Relief Before Granting Leave Under Section 92 CPC
Navigating public charitable trust litigation often raises complex procedural hurdles regarding when courts can intervene. In a recent judgment addressing whether civil courts possess the authority to issue protective interim orders before granting leave to institute a suit, the Supreme Court of India delivered a comprehensive ruling clarifying the statutory boundaries of the Code of […]
Impact of the MCA Exemption on IBC Moratorium for Cape Town Convention related to Aircrafts and other assets: Resolving the Go First Insolvency Crisis
The intersection of domestic insolvency laws and international aviation treaties recently took center stage during the corporate insolvency resolution process of Go Airlines (India) Limited. When the airline filed for voluntary insolvency, the National Company Law Tribunal admitted the plea on May 10, 2023, triggering a strict moratorium under Section 14 of the Insolvency and […]
CCPA Penalizes Britannia for Misleading “100% Whole Wheat Bread” Claims
In a significant move to protect consumer rights, the Central Consumer Protection Authority (CCPA) recently passed an order against Britannia Industries Ltd. for deceptive marketing practices. The regulatory body investigated the company’s prominent advertising claims surrounding its “100% Whole Wheat Bread”. The Core Violation The CCPA took suo-moto cognizance of Britannia’s marketing campaigns across various […]
Arrival of generic Ozempic (semaglutide) in Canada.
The arrival of generic Ozempic (semaglutide) in Canada, following Novo Nordisk’s failure to pay patent fees, is a signal of where the global healthcare and drug pricing landscape is headed. While exclusivity continues in the United States and Europe until the early 2030s, what makes this moment significant is that it offers the world a […]